Nationwide winter weather delays COVID vaccine shipments, forces appointment changes at Geisinger
DANVILLE, Pa. – Due to the severe winter weather that has impacted much of the country, the Centers for Disease Control and Prevention (CDC) has notified several states, including Pennsylvania, that expected COVID vaccine shipments for this week will be delayed.
Due to these delays, it’s necessary to make adjustments to some first-dose vaccine appointments on Wednesday, Feb. 17 and second-dose appointments on Friday, Feb. 19.
- All first-dose vaccine appointments on Wednesday at the Geisinger Lewistown Hospital, Geisinger Health Plan Building (Danville) and Geisinger CenterPoint (Jenkins Township) Vaccine Centers will need to be rescheduled to Sunday, Feb. 28.
- All second-dose vaccine appointments on Friday at the Geisinger Lewistown Hospital, Geisinger Jersey Shore Hospital, Geisinger Health Plan Building (Danville) and Geisinger CenterPoint (Jenkins Township) Vaccine Centers will need to be rescheduled to Sunday, Feb. 21.
Additional adjustments may occur as needed based on supplies and weather. Geisinger is reaching out to those individuals whose vaccine appointments need to be rescheduled to provide a new appointment date and time.
Appointments on Wednesday at the Geisinger Jersey Shore Hospital Vaccine Center are not impacted at this time and remain as scheduled.
For latest vaccine information and weather updates, visit geisinger.org/COVIDvax.
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a research institute and the Geisinger College of Health Sciences, which includes schools of medicine, nursing and graduate education. With more than 25,000 employees and 1,700+ employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and Twitter.